Skip to main content
. 2021 Apr 13;13(4):542. doi: 10.3390/pharmaceutics13040542

Figure 2.

Figure 2

Permeation profiles of IBU in human epidermis after application of 5% IBU formulations expressed as (A) cumulative amounts (μg/cm2) and (B) percentages (%) of the dose applied (mean ± SD; 5 ≤ n ≤ 6, * p < 0.05).